References
- 1. Abbott, J. A., MacLean, H. N., 2006: Two-dimensional echocardiographic assessment of the feline left atrium. J. Vet. Intern. Med., 20, 111—119. DOI: 10.1892/0891-6640(2006) 20[111:teaotf]2.0.co;2.
- 2. Atkins, C. E., Gallo, A. M., Kurzman, I. D., 1992: Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985—1989). J. Am. Vet. Med. Assoc., 201, 613—618.
- 3. Atkins, C. E., 2004: Feline hypertrophic cardiomyopathy 2004. In The 30th Congress of the World Small Animal Veterinary Association Proceedings Online. Mexico City, Mexico, 2005.
- 4. Borgeat, K., Dudhia, J., Luis Fuentes, V., 2015: Circulating concentrations of a marker of type I collagen metabolism are associated with hypertrophic cardiomyopathy mutation status in Ragdoll cats. J. Small Anim. Pract., 56, 360—365. DOI: 10.1111 /jsap.12332.10.1111/jsap.1233225622655
- 5. Connolly, D. J., Cannata, J., Boswood, A., 2003: Cardiac troponin I in cats with hypertrophic cardiomyopathy. J. Feline Med. Surg., 5, 209–—216. DOI: 10.1016/S1098-612X (03)00007-X.
- 6. Côté, E., Harpster, N. K., Laste, N. J., 2004: Atrial fibrillation in cats: 50 cases (1979—2002). J. Am. Vet. Med. Assoc., 225, 256—260.10.2460/javma.2004.225.25615323383
- 7. Crowley, S. D., 2006: Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl. Acad. Sci. USA, 103, 47, 17985—17990. DOI: 10.1073/pnas.0605545103.10.1073/pnas.0605545103169385917090678
- 8. Fearnley, C. J., Roderick, H. L., Bootman, M. D., 2011: Calcium signaling in cardiac myocytes. Cold Spring Harb. Perspect. Biol., 3, 11. DOI: 10.1101/cshperspect.a004242.10.1101/cshperspect.a004242322035221875987
- 9. Fox, P. R., 1988: Canine and feline cardiology. Tijd schr. Diergeneeskd., 113, 21—25.
- 10. Fox, P. R., Liu, S. K., Maron, B. J., 1995: Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy: An animal model of human disease. Circulation, 92, 2645—2651. DOI: 10.1161/01.cir.92.9.2645.10.1161/01.CIR.92.9.26457586368
- 11. Fox, P. R., Oyama, M. A., Reynolds, C., 2009: Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. J. Vet. Cardiol., 11, 51—61. DOI: 10.1016/j.jvc.2008.12.001.10.1016/j.jvc.2008.12.00119394287
- 12. Fox, P. R., Keene, B. W., Lamb, K., 2018: International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study. J. Vet. Intern. Med., 32, 930—943.10.1111/jvim.15285627203230417429
- 13. Fuentes, L. V., Abbott, J., Chetbou, V., Côté, E., 2020: ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats. J. Vet. Int. Med., 34, 1062—1077. DOI: 10.1111/jvim.15745.10.1111/jvim.15745725567632243654
- 14. Habib, M., Hoss, S., Rakowski, H., 2019: Evaluation of hypertrophic cardiomyopathy: newer echo and MRI approaches. Curr. Cardiol. Rep., 11, 51—61. DOI: 10.1016/j. jvc.2008.12.001.
- 15. Häggström, J., Fuentes, V. L., Wess, G., 2015: Screening for hypertrophic cardiomyopathy in cats. J. Vet. Cardiol., 17, 134—149. DOI: 10.1016/j.jvc.2015.07.003.10.1016/j.jvc.2015.07.00326776573
- 16. Herndon, W. E., Kittleson, M. D., Sanderson, K., 2002: Cardiac troponin I in feline hypertrophic cardiomyopathy. J. Vet. Intern. Med., 16, 558—564. DOI: 10.1892/0891-6640 (2002)016< 0558:ctiifh>2.3.co;2.
- 17. Hori, Y., Iguchi, M., Heishima, Y., 2018: Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy. Vet. Intern. Med., 32, 922—929. DOI: 10.1111/jvim. 15131.
- 18. Ironside, V. A., Tricklebank, P. R., Boswood, A., 2020: Risk indictors in cats with preclinical hypertrophic cardiomyopathy: a prospective cohort study. J. Feline Med. Surg., 1, 11. DOI: 10.1177/1098612X20938651.10.1177/1098612X2093865132696726
- 19. Kittleson, M. D., Meurs, K. M., Munro, M. J., 2015: Familial hypertrophic cardiomyopathy in Maine coon cats: an animal model of human disease. Circulation, 99, 3172—80. DOI: 10.1161/01.cir.99.24.3172.10.1161/01.CIR.99.24.3172
- 20. Kittleson, M. D., Coté, E., 2021: The feline cardiomyopathies: Hypertrophic cardiomyopathy. J. Feline Med. Surg., 23, 1028—1051.10.1177/1098612X211020162
- 21. Laste, N. J., Harpster, N. K., 1995: A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977—1993. J. Am. Anim. Hosp. Assoc., 31, 492—500.10.5326/15473317-31-6-492
- 22. Lernfelt, L., 2010: Felin hypertrofisk kardiomyopati— patofysiologi och behandling. Sveriges lantbruksuniversitet Fakulteten för veterinärmedicin och husdjursvetenskap. Uppsala 2010, 18 pp.
- 23. Madron, E., 2004: Hypertrophic Cardiomyopathy in Cats. AVCIM: American College of Veterinary Internal Medicine. https://www.vetspecialists.com/vet-blog-landing/animal-health-articles/2020/04/29/hypertrophic-cardiomyopathyin-cats. Accessed March 15, 2021.
- 24. MacDonald, K. A., Kittleson, M. D., Garcia-Nolen, T., 2006: Tissue Doppler imaging and gradient-echo cardiac magnetic resonance imaging in normal cats and cats with hypertrophic cardiomyopathy. J. Vet. Intern. Med., 20, 627—634. DOI: 10.1892/0891-6640(2006)20[627:tdiage]2.0.co;2.
- 25. McDermott, A., 2018: Diastole vs. systole: A guide to blood pressure. Healthline, 97, 575—580.
- 26. Nistri, S., Olivotto, I., Betocchi, S., 2006: Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian registry for hypertrophic cardiomyopathy). Am. J. Cardiol., 98, 960—965. DOI: 10.1016/j. amjcard.2006.05.013.
- 27. Ortuño, G. C., Sebastián-Marcos, P., Sabater-Molina, M., Nicolas-Rocamora, E., Gimeno-Blanes, J. R., Fernández del Palacio, M. J., 2019: Genetics of feline hypertrophic cardiomyopathy. Clin. Gen., 98, 3, 203—214. DOI: 10.1111/cge.13743.10.1111/cge.13743
- 28. Parmley, W. W., 1985: Pathophysiology of congestive heart failure. Am. J. Cardiol., 55, 9—14. DOI: 10.1016/0002-9149(85)90790-8.10.1016/0002-9149(85)90790-8
- 29. Payne, J. R., Brodbelt, C., Fuentes, V., 2015: Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centers (the CatScan study). J. Vet. Cardiol., 17, 244—257. DOI: 10.1016/j.jvc.2015.03.008.10.1016/j.jvc.2015.03.00826776583
- 30. Reina-doreste, Y., Stern, J. A., Keene, B. W., 2014: Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure. J. Am. Vet. Med. Assoc., 245, 534—539. DOI: 10.2460/javma.245.5.534.10.2460/javma.245.5.53425148095
- 31. Romito, G., Guglielmini, C., Mazzarella, M. O., 2018: Diagnostic and prognostic utility of surface electrocardiography in cats with left ventricular hypertrophy. J. Vet. Cardiol., 20, 364—375. DOI: 10.1016/j.jvc.2018.07.002.10.1016/j.jvc.2018.07.00230082249
- 32. Rush, J. E., 1998: Therapy of feline hypertrophic cardiomyopathy. ScienceDirect., 20, 627-—634.
- 33. Rush, J. E., Freeman, L. M., Fenollosa, N. K., 2002: Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990—1999). J. Am. Vet. Med. Assoc., 220, 202—207. DOI: 10.2460/javma.2002.220.202.10.2460/javma.2002.220.20212126131
- 34. Sciagrà, R., 2016: Positron-emission tomography myocardial blood flow quantification in hypertrophic cardiomyopathy. Q. J. Nucl. Med. Mol. Imaging, 60, 354—361.
- 35. Schipper, T., Van Poucke, M., Sonck, L., Smets, P., Ducatelle, R., Broeckx, B. J. G., Peelman, L. J., 2019: A feline orthologue of the human MYH7 c.5647G>A (p.(Glu1883Lys)) variant causes hypertrophic cardiomyopathy in a Domestic Shorthair cat. Eur. J. Human Gen., 27, 1724—1730.
- 36. Schober, K. E., Zientek, J., Li, X., 2013: Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy. J. Vet. Cardiol., 15, 93—104. DOI: 10.1016/j.jvc.2013.03.003.10.1016/j.jvc.2013.03.00323684504
- 37. Schober, K. E., Chetboul, V., 2015: Echocardiographic evaluation of left ventricular diastolic function in cats: hemo-dynamic determinants and pattern recognition. J. Vet. Cardiol., 17, 102—133. DOI: 10.1016/j.jvc.2015.02.002.10.1016/j.jvc.2015.02.00226776572
- 38. Vezzosi, T., Schober, K. E., 2019: Doppler-derived echocardiographic evidence of pulmonary hypertension in cats with left-sided congestive heart failure. J. Vet. Cardiol., 23, 58—68. DOI: 10.1016/j.jvc.2019.01.007.10.1016/j.jvc.2019.01.00731174730
- 39. Ware, W. A., 1999: Twenty-four-hour ambulatory electrocardiography in normal cats. J. Vet. Intern. Med., 13, 175—180.10.1111/j.1939-1676.1999.tb02174.x
- 40. Wurtinger, G., Henrich, E., Hildebrandt, N., 2017: Assessment of a bedside test for N-terminal pro-B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats. BMC Vet. Res., 13, 394. DOI: 10.1186/s12917-017-1319-6.10.1186/s12917-017-1319-6573877929262821